Professor Lyn Griffiths is Executive Director of the Institute of Health and Biomedical Innovation (IHBI), QUT’s health and medical research institute.
An active and respected molecular geneticist with more than 28 years’ experience, Prof Griffiths has brought business acumen to medical research to increase IHBI’s influence and its impact on human health. She is a passionate advocate for translational research and believes it’s time for Australia to capitalise on its reputation for world-class biomedical research by unlocking its enormous commercial potential. In relation to this, she currently is Director of the nationwide and industry supported Bridge and BridgeTech programs, which provide commercialisation training for the pharmaceutical and medical devices industries, respectively.
Prof Griffiths’ own genetics research has led to diagnostic breakthroughs for several neurogenetic disorders, including familial migraine, ataxia, epilepsy and hereditary stroke. Her research has appeared in more than 350 peer-reviewed international journals, including Nature, the American Journal of Human Genetics, and Nature Neurology.
As the head of IHBI, Prof. Griffiths leads a 1,000-strong research team and sees it as her mission to inspire the next generation of Australian researchers to make the most of funding opportunities to improve human health. She has supervised 54 PhD students and 45 honours students to completion and has led by example when it comes to funding, attracting more than $39 million through national and international grants, industry collaborations, and philanthropy.
A fellow of the Queensland Academy of Arts and Science, Prof. Griffiths has also established several significant international collaborations the Texas Biomedical Research Institute, Oxford University, University of Vienna, the Italian National Research Council, the MS ANZ Gene consortium and the International Migraine Genetics Consortium.